Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a market capitalization of $12.01M and trades at $4.79. The 52-week range is 4.21-17.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.7, Earnings Per Share (EPS) of $-6.64.
The stock has a beta of 1.55, operates in the Healthcare sector.
